The characteristic of Resveratrol to anti-cancer means it has inhibition even deterioration to the three main
stages of the cancer at the start, breeding and development. The scientists in National University of
Singaporehave found by study that Resveratrol can induce the splitting of DNA of leukocyte for HL60 in
human body, and further lead membrane phospholipid to lose non-symmetry. This shows it may induce the
death in sequence of leukocyte for HL60. Another discovery is also found to show that the death of cancer
cells relying on the interaction between CD95 and CD95L. Resveratrol can increase the value of HL60
cells and CD95L in T47Dbreast cancer cell. The scientists treat the breast cancer cell by using Resveratrol,
the result shows CD95 andCD95L system reaching a new balance, which leading 63% of T47D breast
cancer cell dying 18 hours later
.
Deal with the normal ambient blood lymphocyte for healthy people by using Resveratrol, you will see that
72 hours later, comparing with activating ambient lymphocyte individually, no data for Resveratrol to kill the
normal cells. This proves that Resveratrol has optional power to cancer cells.
Resveratrol can inhibit protein tyrosine kinase, which is the material to make catalysis of tyrosine.
Resveratrols inhibition to protein tyrosine kinase is due to act on anti-mutation by inhibiting the function
of kinase. The mechanism is mainly to inhibit the synthesis of cells of DNA and RNA.
Resveratrol has very strong inhibition to the reaction of lipid peroxidation caused by free radical syste
m, also stronger inhibition to lipid peroxidation on the model of artificial cell of lecithin lipid. It can obviously
reduce the content of MDA in the tissues, increase the activation of SOD, CAT and GSH-px, thus with
protective effect to cerebral anaemia and tissue damages.
Resveratrol may strengthen the immunity. It can also recover the inhibited characteristic of cells in the burnt
rat, with effective power to the reactive ability of damagedantigen singal, to breeding ability, to synthetic
ability of white blood cell medium Άς and to synthetic ability of antibody through lymph cell.